SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-19-001781
Filing Date
2019-03-11
Accepted
2019-03-11 16:56:23
Documents
3
Period of Report
2019-03-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K f8-k.htm 8-K 23040
2 EX-99.1 ex-99d1.htm EX-99.1 249067
3 GRAPHIC ex-99d1g001.jpg GRAPHIC 4036
  Complete submission text file 0001558370-19-001781.txt   278939
Mailing Address 100 BEAVER STREET SUITE 201 WALTHAM MA 02453
Business Address 100 BEAVER STREET SUITE 201 WALTHAM MA 02453 781-996-5252
Kala Pharmaceuticals, Inc. (Filer) CIK: 0001479419 (see all company filings)

IRS No.: 270604595 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38150 | Film No.: 19672898
SIC: 2834 Pharmaceutical Preparations